University of California, Los Angeles

Response-Based Imaging Endpoints for Recurrent Glioblastoma Clinical Trials

Principal Investigators: Benjamin M. Ellingson, Ph.D., Patrick Wen, M.D., and Timothy F. Cloughesy, M.D.

Institute: University of California, Los Angeles and Dana-Farber Cancer Institute

Initiative: Clinical Trials Endpoints

Location: Los Angeles, CA and Boston, MA

Critical role of STAT3 in medulloblastoma immune evasion in genetically engineered mice

Principal Investigator: James Waschek, PhD

Institute: University of California, Los Angeles

Initiative: Advanced Research Grant

Location: Los Angeles, CA

Identification of therapeutic targets in glioblastoma stem cells

Principal Investigator: Cho-Lea Tso, PhD

Institute: University of California, Los Angeles

Initiative: Glioblastoma Multiforme Grant

Location: Los Angeles, CA

Molecularly Guided Clinical Trials for Glioma

Principal Investigator: Paul Mischel, MD

Institute: University of California, Los Angeles

Initiative: Unrestricted Grant

Location: Los Angeles, CA

The role of PTEN tumor suppressor in regulating neural stem cells and tumorigenesis

Principal Investigator: Xin Liu, MD, PhD

Institute: University of California, Los Angeles

Initiative: Unrestricted Grant

Location: Los Angeles, CA

Principal Investigator: Xin Liu, MD, PhD

Institute: University of California, Los Angeles

Initiative: Unrestricted Grant

Location: Los Angeles, CA

Share